ArticleMaterials today. Bio2026
Multifunctional scaffold inspired by hepatocyte exosomes promotes bone regeneration by regulating osteogenic differentiation via PI3K/AKT pathway.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exosome-mediated tissue-tissue communication represents a fundamental mechanism that maintains physiological homeostasis. This study proposes a novel therapeutic approach based on liver-bone cross-talk, wherein hepatocyte-derived exosomes (h-EXOs) markedly accelerated the repair of critical cranial defects. Specifically, h-EXOs were anchored onto a digital light processing (DLP)-printed scaffold (PH/PDA) composed of polycaprolactone macromolecule polymer (PCLMA) and nano-hydroxyapatite (nHap) via a polydopamine (PDA) coating to promote cranial bone regeneration. These PH/PDA scaffolds substantially enhanced bone mesenchymal stem cells (BMSCs) adhesion and proliferation, while the incorporated h-EXOs significantly promoted angiogenesis and osteogenic differentiation. Moreover, RNA sequencing revealed that h-EXOs were enriched in cargoes governing diverse cellular processes and activated the PI3K/AKT pathway to promote BMSCs osteogenesis. Following implantation, PH/PDA/h-EXOs scaffolds induced substantial defect closure and fostered a regenerative microenvironment similar to native calvarial tissue, characterized by an expansion of anti-inflammatory M2 macrophages and osteoblasts alongside pronounced vascularization. Overall, this study leverages inter-organ crosstalk in conjunction with personalized scaffold fabrication to propose a novel tissue-engineering strategy for enhancing tissue repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.